AFC-HD AMS Life Science Co., Ltd.
2927.T · JPX
8/31/2025 | 8/31/2024 | 8/31/2023 | 8/31/2022 | |
|---|---|---|---|---|
| Market Cap | ¥12 | ¥12 | ¥11 | ¥11 |
| - Cash | ¥11 | ¥12 | ¥11 | ¥10 |
| + Debt | ¥24 | ¥23 | ¥20 | ¥17 |
| Enterprise Value | ¥25 | ¥22 | ¥20 | ¥18 |
| Revenue | ¥33 | ¥30 | ¥26 | ¥23 |
| % Growth | 8.2% | 18% | 11.2% | – |
| Gross Profit | ¥11 | ¥10 | ¥9 | ¥9 |
| % Margin | 33.6% | 34.8% | 36.4% | 37.3% |
| EBITDA | ¥4 | ¥3 | ¥3 | ¥2 |
| % Margin | 11.6% | 10.3% | 10.1% | 10% |
| Net Income | ¥1 | ¥1 | ¥1 | ¥1 |
| % Margin | 4.4% | 4.1% | 4.3% | 3.2% |
| EPS Diluted | 102.97 | 88.96 | 78.46 | 52.08 |
| % Growth | 15.7% | 13.4% | 50.7% | – |
| Operating Cash Flow | ¥2 | ¥2 | ¥1 | ¥1 |
| Capital Expenditures | -¥4 | -¥3 | -¥2 | -¥1 |
| Free Cash Flow | -¥2 | -¥2 | -¥1 | ¥1 |